children with human immunodeficiency virus (HIV) infection is difficult to diagnose and progresses rapidly to death. 1 Because positive cultures occur in less than 40% of pediatric cases, 2 presumptive diagnosis of active TB in this population is often based on clinical criteria without microbiological confirmation. 1, 2 This leads to over-diagnosis since active TB is easily confused with other HIV-associated lung conditions. 3 However, the diagnosis of active TB should be pursued in symptomatic HIV-infected children to ensure early treatment and improve survival.
The aim of this preliminary study was to investigate the prevalence and clinical correlates of TB-related illness among HIV-infected children admitted to an infectious diseases ward in Peru, a country where TB is highly endemic.
For purposes of the study, TB-positive children were defined by the presence of any positive test for TB, including positive auramine stain, positive culture for Mycobacterium tuberculosis (MTB), or positive results with the hemi-nested IS6110 polymerase chain reaction assay developed by our group. 4 At least two respiratory secretion cultures, defined as sputa, nasopharyngeal aspirates (NPA), and nasogastric aspirates (NGA), were obtained from each subject. TB culture of NPA specimens was shown to have a similar yield to NGA specimens in a previously published pediatric study from this site. 5 While a positive PCR result is less definitive than a positive culture and could impact case specificity, we believe that combining PCR and culture in the case definition provides a more accurate method of case ascertainment than culture and/or smear alone, which have very reduced sensitivity for the detection of MTB disease in children. While any operational definition of pediatric TB has limitations, especially in an HIV-infected population, we chose this definition to identify the subgroup of HIV-infected children most likely to have TB-related disease to compare them with HIV-infected children admitted for other infectious complications.
Methods
From January to December 2000, we enrolled children under 14 years of age who had documented HIV infection and were hospitalized at the Instituto de Salud del Niño in Lima, Peru, for evaluation of any suspected infectious disease process. HIV infection was confirmed by Western blot and HIV-1 env DNA gene detection by PCR. 6 Children on antituberculous treatment or unable to provide specimens for TB screening were excluded. Demographic and clinical information was collected. Bacillus Calmette-Guérin (BCG) immunization was recorded based on presence of BCG scar, and TB skin testing (TST) with purified protein derivative was performed. Nutritional status was assessed using Z scores, and chest Xrays were examined by a pediatric pulmonologist. CD4+ lymphocytes were measured using the Becton Dickinson Immunocytometry System, using %CD4+ for immunological status determination as recommended by the Centers for Disease Control and Prevention (no suppression: %CD4+ 25, moderate suppression: %CD4+ = 15-24, and severe suppression: %CD4+ < 15). 7 At the time of the study antiretroviral treatment was only available for a limited number of children through non-governmental organizations, and it was not available through this study.
Children were asked to provide spontaneous sputum (Sp) when able, otherwise nasogastric (NGA) and/or nasopharyngeal aspirates (NPA) were obtained. At least two specimens categorized as Sp, NGA, or NPA were obtained from Tuberculosis co-infection in HIV-infected children in Peru 279 each subject analyzed. Two stool (S) specimens were also analyzed for each subject, and bronchoalveolar lavage (BAL) and cerebrospinal fluid (CSF) were collected if clinically indicated. All the specimens were screened for TB using auramine stain, microscopic observation drug susceptibility (MODS) culture technique, and nested IS6110 polymerase chain reaction (PCR), following previously described techniques. 4, 8 Children with any positive test for TB by culture or PCR were classified as TB-positive. All laboratory results were provided to clinicians managing the children's medical therapy, and individual decisions about antituberculous therapy were made by clinicians with the aid of these results.
Epidemiological and clinical characteristics of TB-positive and TB-negative subjects were compared using the Fisher's exact test and the Student's t-test. Odds ratios (OR) were estimated by exact logistic regression to evaluate risk factors by using LogXact version 5.0. This method yields exact p values and confidence intervals (CI) no matter how small or imbalanced are the data. Quantitative variables not following normal distribution were analyzed with nonparametric statistics to compare distributions (Mann-Whitney U-test). Categorization of the duration of any symptom was done using the concept of suspected TB disease in a patient with a history of two or more weeks of complaints. ORs were adjusted by age, %CD4+, and chronic malnutrition (weight-for-height less than two standard deviations (<2 SD) below the mean). Written consent for inclusion into the study was obtained from the participant's caregivers. The Institutional Review Boards of the Johns Hopkins Bloomberg School of Public Health, the Asociación Benéfica PRISMA, and the Instituto de Salud del Niño of Lima, Peru approved the study.
Results
Epidemiological and clinical characteristics of the 47 children are summarized in the TB-positive and TB-negative groups in Table 1 . In the entire study population, 53% were male, and the mean age was 3.6 years (range 0.3-12.2 years). Eightythree percent of the children reported respiratory complaints, 83% had fever, and 55% had diarrhea. All children had a TST response of 0 mm. Fifty-seven percent of the children had height-for-age >2 SD below the US National Center for Health Statistics (NCHS) mean, and 34% had weight-for-height >2 SD below the mean. Flow cytometry data were available for 90% of the children, with a median %CD4+ count of 11%.
Seventeen percent of the children (8/47) were TB-positive. Among the eight TB-positive children, three were positive by PCR test only, two by culture only, and three by both culture and PCR ( Table 2 ). None of the specimens were auramine stain positive. Culture-positive specimens were stool in three cases and one case each in NPA and cerebrospinal fluid. No significant differences in age, gender, and %CD4+ were found between TB-positive and TB-negative children. For those children who reported a weight loss the median time for TB-positive children was 2.4 weeks (range 1-8), and for TB-negative children was 2.0 weeks (range 1-20). Weight loss (OR = 8.86, 95% CI = 1.24, infinity, p = 0.027) was significantly associated with TB disease. Weight loss for two or more weeks was a marginal significant risk factor for TB disease (OR = 5.45, 95% CI = 0.91-32.61, p = 0.063). After controlling for age in weeks, %CD4+, and chronic malnutrition, weight loss (adjusted OR = 13.99, 95% CI = 1.34, infinity, p = 0.025) and weight loss for more than two weeks (OR = 11.16, 95% CI = 1.18-105.45, p = 0.035) remained significantly associated with TB disease. Radiological alterations were common even in the TB-negative group, with no significant difference in radiological patterns between the two groups.
Discussion
Because adequate detection of MTB is difficult in young children with pulmonary disease, establishing a diagnosis of active TB in children remains challenging. In children, results of smears and cultures from samples obtained by invasive and non-invasive methods are often falsely negative. 9,10 Many clinicians use a clinical case definition of TB based on a scoring system that includes: TST, clinical signs and symptoms consistent with TB, abnormal chest radiography, contact investigation, and therapeutic response. 2 These systems frequently fail to identify active TB in HIVinfected children, leading to inaccurate diagnosis and making the diagnosis of TB highly speculative. 3 In this study, even when the majority of the children had pulmonary symptoms suggestive of pulmonary TB (PTB), only 280
M.E. Ramírez-Cardich et al. 17% had a positive test and 10% were culture-proven, which agrees with previous reports. 11 Interestingly, three of the five culture-positive cases were detected by stool culture, a method which is often not attempted. Stool culture for MTB is relatively insensitive and technically challenging, but it has been used successfully in many developing countries 12, 13 and deserves consideration because the specimen is so easily obtainable. Because the diagnosis of active TB in this population is uncertain, any clinical strategy that results in improved detection of MTB will potentially improve survival by promoting early use of anti-TB therapy. Any HIV-infected children with signs suggestive of lung involvement should be screened for TB disease, especially if there is a history of weight loss. In this study all of the TB-positive children had lung involvement, and weight loss was the only predictive clinical feature for a positive TB test, even after removing the effect of the immune status and age.
The diagnosis of active TB cases in this study relied on the PCR and culture results, which are the only possible means of detecting TB disease in our environment, in spite of their limitations as previously described. While PCR has been used for PTB screening in children, 4, 14 the clinical significance of a positive PCR result in TB-infected patients without clinical disease is difficult to interpret, as it may represent latent infection or low-grade active disease. 10 However, until new effective diagnostic tools become available, HIV-infected children with a positive PCR test should be treated as if they have active TB, because their immunosuppression and their high risk for developing active disease justify it. 2, 14 In populations such as ours, weight loss may be a useful marker to identify HIV-infected children at increased risk for clinical TB.
